Zimmer Biomet Holdings Inc. and Monogram Technologies Inc., an orthopedic robotics company, have announced that they have ...

First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting ...

Investing.com -- The U.S. Food and Drug Administration has approved gardenia (genipin) blue for use in various foods, marking the fourth natural color additive approved in the last two months.

Investing.com -- BiomX (NYSE: PHGE) Inc. (NYSE American:PHGE) stock surged 60% after the clinical-stage company announced it has successfully initiated patient dosing in its Phase 2b trial evaluating ...

A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

The Food and Drug Administration (FDA), in collaboration with the National Institutes of Health (NIH), hosted a workshop ...

Corcept Therapeutics has filed for U.S. Food and Drug Administration approval of its relacorilant drug candidate for the treatment of patients with platinum-resistant ovarian cancer.

FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

WHO has officially recommended twice-yearly injectable lenacapavir for HIV prevention, marking a major shift in global HIV ...

A phenotype-based profiling test can help predict whether a patient might respond better to one antiobesity medicine or ...